MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.

Source:http://linkedlifedata.com/resource/pubmed/id/20103675

Clin. Cancer Res. 2010 Feb 1 16 3 867-75

Download in:

View as

General Info

PMID
20103675